Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Pharmaceutical Group Jinkang Pharmaceutical is a core subsidiary of the Tianjin Pharmaceutical Group, specializing in the development and large-scale production of chemical drug substances and finished dosage forms. The company operates as a significant manufacturing base for the group, focusing on therapeutic areas such as cardiovascular health, metabolic disorders, and anti-infectives. Its facilities are GMP-certified, enabling the production of a wide range of generic medications including antihypertensives, antidiabetics, and antibiotics. Jinkang Pharmaceutical serves both the domestic Chinese market and international clients through the export of active pharmaceutical ingredients (APIs) and finished products. The company is integral to the supply chain of essential medicines within the Tianjin Pharmaceutical Group's broader healthcare portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Pharmaceutical Group Jinkang Pharmaceutical.